NETOBIMIN Price — China Factory EXW 2026

NETOBIMIN price Spec: China national standards

China EXW, VAT excluded

Newest China EXW USD 13,185.84 / MT · VAT excluded unchanged as of 20210320

Newest Price 13,185.84

Price Date 20210320

Day's Change 0

Day's Range 13,185.84 - 13,185.84

Month's Change +37,592.92

Month's Range 13,185.84 - 50,778.76

Year's Change -17,955.75

Year's Range 13,185.84 - 31,141.59

The shift away from nevirapine mirrors a broader trend in China's ART market toward single-tablet regimens with better safety profiles. However, nevirapine's low cost and stable su...

Also known as amino)methylene)amino)- ethanesulfonicacid,2-(((methoxycarbonyl)amino)((2-nitro-5-(propylthio)phenyl) hapasil Neviyapine

Opinions

How do nevirapine's side effects and CD4 restrictions impact its use in China's HIV treatment market?

The shift away from nevirapine mirrors a broader trend in China's ART market toward single-tablet regimens with better safety profiles. However, nevirapine's low cost and stable supply through government programs still make it indispensable for budget-constrained patients. Watch for policy changes on free drug lists, as any update could significantly alter demand volumes for domestic API producers like Huahai.

What is the supply-demand outlook for nevirapine API given Huahai's FDA certification and global competition?

Global nevirapine API capacity is concentrated among a few Indian and Chinese players. With US tariffs targeting Chinese APIs, Indian competitors may gain pricing power in Western markets. However, China's domestic procurement volumes remain stable, and Huahai's FDA-approved facility gives it a regulatory moat that smaller domestic producers lack. Price competition in tenders will likely intensify as the product lifecycle matures.

NETOBIMIN price context

What drives NETOBIMIN prices

How do nevirapine's side effects and CD4 restrictions impact its use in China's HIV treatment market?: The shift away from nevirapine mirrors a broader trend in China's ART market toward single-tablet regimens with better safety profiles. However, nevirapine's lo...

What is the supply-demand outlook for nevirapine API given Huahai's FDA certification and global competition?: Global nevirapine API capacity is concentrated among a few Indian and Chinese players. With US tariffs targeting Chinese APIs, Indian competitors may gain prici...

How we assess NETOBIMIN price

China factory / mainstream market EXW quotes (VAT excluded where shown) - not a single global public index

Regional and specification detail so buyers can compare like-for-like grades

Landed cost figures from our calculator are planning estimates, not a customs ruling

Overview

Nevirapine (NETOBIMIN, CAS 88255-01-0) is a white to off-white crystalline solid used as a first-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV-1 treatment. It was the first NNRTI discovered, developed by Boehringer Ingelheim and approved in 1996.

Pharmaceuticals: active ingredient in antiretroviral therapy, often combined with zidovudine and lamivudine in fixed-dose combinations.
HIV prevention: used in single-dose regimens to reduce mother-to-child transmission during childbirth.
Research: subject of continuous-flow microreactor studies for safer amination and cyclization steps in synthesis.

China's production landscape includes domestic manufacturing of the active pharmaceutical ingredient and finished formulations, with nevirapine being the first Chinese product to receive a US ANDA for HIV drugs. Continuous-flow hydrogenation technology is being explored to replace batch processes, improving safety and efficiency. The domestic market is largely driven by national free antiretroviral treatment programs.

Key domestic producers:
Huahai Pharmaceutical – first Chinese firm to export nevirapine tablets to the US market.
Shanghai Desano Biopharmaceutical – developed the domestic three-in-one fixed-dose combination containing nevirapine.

Properties

Name

NETOBIMIN

amino)methylene)amino)- ethanesulfonicacid,2-(((methoxycarbonyl)amino)((2-nitro-5-(propylthio)phenyl) hapasil Neviyapine

CAS Number

88255-01-0

Cookie Preferences

Essential Cookies

Analytics Cookies

ChemPriceHub